Alvotech (ALVO)
13.94
+0.06
(+0.43%)
USD |
NASDAQ |
Jun 03, 16:00
13.94
0.00 (0.00%)
After-Hours: 20:00
Alvotech Cash from Operations (TTM): -301.46M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -301.46M |
December 31, 2023 | -312.18M |
September 30, 2023 | -309.40M |
Date | Value |
---|---|
June 30, 2023 | -299.24M |
March 31, 2023 | -360.94M |
December 31, 2022 | -312.39M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-360.94M
Minimum
Mar 2023
-299.24M
Maximum
Jun 2023
-315.93M
Average
-310.79M
Median
Cash from Operations (TTM) Benchmarks
AbbVie Inc | 22.69B |
Moolec Science SA | -12.58M |
Teva Pharmaceutical Industries Ltd | 1.389B |
Procaps Group SA | 62.99M |
NeuroMetrix Inc | -7.045M |